However, Chang et al. found that miR-20a reduces the proportion of IL-17+ cells in CD4+ T cells of patients with Vogt-Koyanagi-Harada disease by targeting OSM and CCL1 [46]. This evidence concerns the gene CCL1 and Vogt-Koyanagi-Harada disease.